Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

9.7%

3 terminated/withdrawn out of 31 trials

Success Rate

89.3%

+2.8% vs industry average

Late-Stage Pipeline

39%

12 trials in Phase 3/4

Results Transparency

72%

18 of 25 completed trials have results

Key Signals

18 with results

Enrollment Performance

Analytics

Phase 1

10(34.5%)

Phase 3

9(31.0%)

Phase 2

4(13.8%)

N/A

3(10.3%)

Phase 4

3(10.3%)

29Total

Phase 1(10)

Phase 3(9)

Phase 2(4)

N/A(3)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (31)

Showing 20 of 31 trials

NCT03656926Phase 3Completed

Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2)

Role: lead

NCT03657342Phase 3Completed

Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-1)

Role: lead

NCT03999021Phase 1Active Not Recruiting

FIGHT-RP 1 Extension Study

Role: collaborator

NCT03843541Phase 3Completed

A Clinical Trial to Compare the Efficacy and Safety of 1-week Treatment of Intravenous N-acetylcysteine (NAC) 600 mg Twice Daily, Ambroxol Hydrochloride 30 mg Twice Daily and Placebo as Expectorant Therapies in Adult Chinese Patients With Respiratory Tract Diseases and Abnormal Mucus Secretions

Role: lead

NCT06503770Completed

A Retrospective Chart Review Study of Patients With Chronic Lung Allograft Dysfunction-Bronchiolitis Obliterans Syndrome (CLAD-BOS) Post Lung Transplantation

Role: lead

NCT04819438Phase 1Completed

Riluzole Orodispersible Film Replicate Bioavailability

Role: collaborator

NCT04039347Phase 3Active Not Recruiting

Extension Trial on Efficacy / Safety of L-CsA + SoC in Treating BOS in Post Single or Double Lung Transplant (BOSTON-3)

Role: lead

NCT03994328Completed

An Observational Study on Safinamide, Rasagiline and Other Standard of Care in PD

Role: lead

NCT03881371Phase 3Completed

A Study to Evaluate the Efficacy and Safety of Safinamide, as add-on Therapy, in Idiopathic Chinese Parkinson's Disease (PD) Patients With Motor Fluctuations Treated With Stable Doses of Levodopa

Role: lead

NCT03460704Phase 3Terminated

Trial in Non-cystic Fibrosis Bronchiectasis Patients With Chronic Lung Infections Treated With Colistimethate Sodium.

Role: lead

NCT03830190Not ApplicableCompleted

Cost-effectiveness of Nursing Interventions for Patients With PD

Role: collaborator

NCT03093974Phase 3Completed

Efficacy and Safety of Inhaled CMS in Bronchiectasis Subjects With Chronic P. Aeruginosa Infection. (PROMIS-I)

Role: lead

NCT04107675Phase 2Terminated

A Safety Study of Liposomal Cyclosporine A to Treat Bronchiolitis After Hematopoietic Transplant (BOSTON-4)

Role: lead

NCT03841604Phase 4Completed

Effect of Safinamide on Parkinson's Disease Related Chronic Pain

Role: lead

NCT03887221Phase 1Completed

A Single and Multiple Dose Study to Assess How the Drug Enters, Moves Through and Exits the Body, Safety and Tolerability of Safinamide in Healthy Adult Chinese Volunteers

Role: lead

NCT02237508Phase 1Completed

A Clinical Study to Evaluate Z7200 (Budesonide/Formoterol) Pharmacokinetics Profile in Healthy Volunteers

Role: lead

NCT02631941Phase 1Completed

Clinical Study to Evaluate Z7200 Pharmacokinetics Profile

Role: lead

NCT02227394Phase 2Completed

Study to Compare the Effects of Z7200 And Symbicort® Turbohaler on Respiratory Imaging Parameters in Asthmatic Patients

Role: lead

NCT04229303Phase 1Completed

Phase 1 Three Part SAD, MAD & Cross-Over Study of ZP-059 in Healthy and Asthmatic Subjects